Interview
The Challenges Behind the COVID-19 Vaccines Rollout
- The U.S. is projected to require 500 million vaccinations and the global market 10 billion shots within a "fairly short amount of time."
- Approximately 2 to 3 billion additional vaccine vials are estimated to be needed globally, assuming a multi-dose format of five to six doses per vial.
- The supply of 10 billion syringes and needles is considered achievable due to industry investment and lead time established since May 2020.
- Future vaccine availability is expected to increase storage stability, including options for normal refrigeration and extended out-of-freezer times of up to five days.
- Government-held second-dose supplies are anticipated to be released soon to increase overall availability.
- Vaccination demand is forecasted to rise over time as efficacy data expands and more successful administrations occur.
- Clinical data regarding vaccine efficacy and safety for children is expected to be released during the course of the year.
- Vaccination strategies are planned to prioritize populations most at risk to reduce burdens on the healthcare system.
- Emerging markets are expected to benefit significantly from vaccines compatible with standard refrigeration temperatures.